U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07094672) titled 'Development of an Opioid Withdrawal Clinical Outcome Assessment' on July 23.
Brief Summary: Withdrawal management strategies are currently the most utilized and ubiquitous intervention for opioid use disorder in the US, yet existing measures of opioid withdrawal lack Food and Drug Administration (FDA) qualification. This project will develop and validate a clinical outcome assessment (COA) for opioid withdrawal,essential for standardizing withdrawal mitigation strategies and establishing best practices. In line with the FDA's drug development tool qualification guidelines, our methodological process will involve conducting focus gro...